iStar Medical Announces First Patient Implanted with STARflo™ Glaucoma Drainage Device in European Clinical Trial

Isnes, Belgium (Oct 30, 2014) – iSTAR Medical SA, a privately held ophthalmic device company, announced today that the first patient in its European multi-center clinical trial has been successfully implanted with the STARflo glaucoma drainage device.

Read more

iSTAR Medical appoints Michel Vanbrabant Chief Executive Officer

Isnes, Belgium (July 16, 2014) – iSTAR Medical SA, a privately held ophthalmic device company, announced today that Michel Vanbrabant has been appointed Chief Executive Officer and member of the Board of Directors.

Read more

iSTAR Medical Adds Glaucoma Pioneer Prof. Michael Belkin, MD, to Scientific Advisory Board

Isnes, Belgium (April 29, 2014) – iSTAR Medical SA (iSTAR), a medical device company specializing in ophthalmic implants, announced today the addition of Prof. Michael Belkin, MD, to its Scientific Advisory Board (SAB). Prof. Belkin is professor emeritus of Ophthalmology at Tel-Aviv University where he is the director of the Ophthalmic Technologies Laboratory at the university’s Eye Research Institute, located at the Sheba Medical Center, Israel, and serves as senior advisor to the Singapore Eye Research Institute.
Read more